What is VesCell™ PAD treatment?
VesCell™ PAD is the latest generation adult stem cell technology developed by TheraVitae. VesCell™ PAD uses a patient’s own adult stem cells to treat severe Peripheral Artery Disease of the lower limbs and is a viable therapy for patients who have exhausted all other treatment options short of amputation. VesCell™ PAD uses adult stem cells that are harvested from approximately ½ pint of the patient’s own blood. In the lab, these adult stem cells are transformed into a therapeutic dose of cells called Angiogenic Cell Precursors (ACPs). ACPs are stem cells that induce the growth of blood vessels in diseased areas of the body. Emerging research suggests that ACPs may also form additional cell types and secrete compounds conducive for growth. The first generation of ACPs, VesCell™, has been used to successfully treat over 200 heart disease patients.
VesCell PAD is the latest generation adult stem cell technology developed by TheraVitae. VesCell PAD uses a patient’s own adult stem cells to treat severe Peripheral Artery Disease of the lower limbs and is a viable therapy for patients who have exhausted all other treatment options short of amputation. VesCell PAD uses adult stem cells that are harvested from approximately ½ pint of the patient’s own blood. In the lab, these adult stem cells are transformed into a therapeutic dose of cells called Angiogenic Cell Precursors (ACPs). ACPs are stem cells that induce the growth of blood vessels in diseased areas of the body. Emerging research suggests that ACPs may also form additional cell types and secrete compounds conducive for growth. The first generation of ACPs, VesCell, has been used to successfully treat over 200 heart disease patients.
